Current through Register 1531, September 27, 2024
(1)
General
Requirements.
(a)310 CMR 22.20G
establishes or extends Treatment Technique requirements in
lieu of Maximum Contaminant Levels for
Cryptosporidium. These requirements are in addition to
requirements for Filtration and Disinfection in
310 CMR
22.20A,
22.20D,
and
22.20F.
(b) Applicability. 310 CMR 22.20G applies to
all suppliers of water using a Surface Water Source, or groundwater source
under the direct influence of surface water.
1. Wholesale Systems, as defined in
310 CMR 22.02, must
comply with the requirements of 310 CMR 22.20G based on the population of the
largest system in the Combined Distribution System.
2. The requirements of 310 CMR 22.20G for
filtered systems apply to systems required by National Primary Drinking Water
Regulations and
310 CMR
22.00 to provide Filtration treatment, whether or not
the system is currently operating a Filtration system.
3. The requirements of 310 CMR 22.20G for
unfiltered systems apply only to unfiltered systems that timely met and
continue to meet the Filtration avoidance criteria in
310 CMR
22.20A,
22.20D,
and
22.20F,
as applicable.
(c)
Requirements. Systems subject to 310 CMR 22.20G must
comply with the following requirements:
1.
Systems must conduct an initial and a second round of source water monitoring
for each plant supplied by a Surface Water Source, or groundwater source under
the direct influence of surface water. This monitoring may include sampling for
Cryptosporidium, E. coli, and Turbidity as
described in 310 CMR 22.20G(2) through (7), to determine what level, if any, of
additional Cryptosporidium treatment the public water supplier
must provide.
2. Systems that plan
to make a significant change to their Disinfection practice must develop
Disinfection Profiles and calculate Disinfection benchmarks, as described in
310 CMR 22.20G(9) through (10).
3.
Filtered systems must determine their Cryptosporidium
treatment bin classification as described in 310 CMR 22.20G(11) and provide
additional treatment for Cryptosporidium, if required, as
described in 310 CMR 22.20G(12). All unfiltered systems must provide treatment
for Cryptosporidium as described in 310 CMR 22.20G(13).
Filtered and unfiltered systems must implement Cryptosporidium
treatment according to the schedule in 310 CMR 22.20G(14).
4. Systems with uncovered finished water
storage facilities must comply with the requirements to cover the facility or
treat the discharge from the facility as described in 310 CMR
22.20G(15).
5. Systems required to
provide additional treatment for Cryptosporidium must
implement microbial toolbox options that are designed and operated as described
in 310 CMR 22.20G(19) through (23).
6. Systems must comply with the applicable
recordkeeping and reporting requirements described in 310 CMR 22.20G(16) and
(17).
(2)
Source Water Monitoring.
(a)
Initial Round of Source Water
Monitoring. Systems must conduct the following monitoring on the
schedule in 310 CMR 22.20G(2)(c) unless they meet the monitoring exemption
criteria in 310 CMR 22.20G(2)(d).
1. Filtered
systems serving at least 10,000 people must sample their source water for
Cryptosporidium, E. coli, and Turbidity at
least monthly for 24 months.
2.
Unfiltered systems serving at least 10,000 people must sample their source
water for Cryptosporidium at least monthly for 24
months.
3.
a. Filtered systems serving fewer than 10,000
people must sample their source water for E. coli at least
once every two weeks for 12 months.
b. A filtered system serving fewer than
10,000 people may avoid E. coli monitoring if the system
notifies the Department that it will monitor for Cryptosporidium
as described in 310 CMR 22.20G(2)(a)4. The system must notify the
Department no later than three months prior to the date the system is otherwise
required to start E. coli monitoring under 310 CMR
22.20G(2)(c).
4.
Filtered systems serving fewer than 10,000 people must sample their source
water for
Cryptosporidium at least twice per month for 12
months or at least monthly for 24 months if they meet one of the following,
based on monitoring conducted in accordance with the requirements of 310 CMR
22.20G(2)(a)3.:
a. For systems using
Lake/Reservoir sources, the annual mean E. coli concentration
is greater than 10 E. coli/ 100 mL.
b. For systems using flowing stream sources,
the annual mean E. coli concentration is greater than 50
E. coli/ 100 mL.
c. The system does not conduct E.
coli monitoring as described in 310 CMR 22.20G(2)(a)3.
d. Systems using Groundwater under the Direct
Influence of Surface Water must comply with the requirements of 310 CMR
22.20G(2)(a)4. based on the E. coli level that applies to the
nearest Surface Water body. If no Surface Water body is nearby, the system must
comply based on the requirements that apply to systems using Lake/Reservoir
sources.
5. For filtered
systems serving fewer than 10,000 people, the Department may approve monitoring
for an indicator other than E. coli under 310 CMR
22.20G(2)(a)3. The Department also may approve an alternative to the E.
coli concentration as specified in 310 CMR 22.20G(2)(a)4.a., b. or d.
to trigger Cryptosporidium monitoring. This approval by the
Department will be provided to the system in writing and will include the basis
for the Department's determination that the alternative indicator and/or
trigger level will provide a more accurate identification of whether a system
will exceed the Bin 1 Cryptosporidium level in 310 CMR
22.20G(11).
6. Unfiltered systems
serving fewer than 10,000 people must sample their source water for
Cryptosporidium at least twice per month for 12 months or at
least monthly for 24 months.
7.
Systems may sample more frequently than required under 310 CMR 22.20G(2) if the
sampling frequency is evenly spaced throughout the monitoring period.
(b)
Second Round of
Source Water Monitoring. Systems must conduct a second round of
source water monitoring that meets the requirements for monitoring parameters,
frequency, and duration described in 310 CMR 22.20G(2)(a), unless they meet the
monitoring exemption criteria in 310 CMR 22.20G(2)(d). Systems must conduct
this monitoring on the schedule in 310 CMR 22.20G(2)(c).
(c)
Monitoring
Schedule. Systems must begin the monitoring required in 310 CMR
22.20G(2)(a) and (b) no later than the month beginning with the date listed in
310 CMR 22.20G:
Table 1.
310 CMR 22.20G: Table 1
SOURCE WATER MONITORING STARTING DATES
Systems that serve:
|
Must begin the first round of source water monitoring
no later than the month beginning:
|
And must begin the second round of source water
monitoring no later than the month beginning:
|
At least 100,000 people
|
October 1, 2006
|
April 1, 2015
|
From 50,000 to 99,999 people
|
April 1, 2007
|
October 1, 2015
|
From 10,000 to 49,999 people
|
April 1, 2008
|
October 1, 2016
|
Fewer than 10,000 and monitor for E.
coli1
|
October 1, 2008
|
October 1, 2017
|
Fewer than 10,000 and monitor for
Cryptosporidium2
|
April 1, 2010
|
April 1, 2019
|
1 Applies only to filtered
systems.
2 Applies to filtered systems that
meet the conditions of 310 CMR 22.20G(2)(a)4. and unfiltered systems.
(d)
Monitoring
Avoidance.
1. Filtered systems
are not required to conduct source water monitoring under 310 CMR 22.20G if the
system will provide a total of at least 5.5-log of treatment for
Cryptosporidium, equivalent to meeting the treatment
requirements of Bin 4 in 310 CMR 22.20G(12).
2. Unfiltered systems are not required to
conduct source water monitoring under 310 CMR 22.20G if the system will provide
a total of at least 3-log Cryptosporidium inactivation,
equivalent to meeting the treatment requirements for unfiltered systems with a
mean Cryptosporidium concentration of greater than 0.01
oocysts/L in 310 CMR 22.20G(13).
3. If a system chooses to provide the level
of treatment in 310 CMR 22.20G(2)(d)1. or 2., as applicable, rather than start
source water monitoring, the system must notify the Department in writing no
later than the date the system is otherwise required to submit a sampling
schedule for monitoring under 310 CMR 22.20G(3). Alternatively, a system may
choose to stop sampling at any point after it has initiated monitoring if it
notifies the Department in writing that it will provide this level of
treatment. Systems must install and operate technologies to provide this level
of treatment by the applicable treatment compliance date in 310 CMR
22.20G(14).
(e)
Plants Operating Only Part of the Year. Suppliers of
water with plants served by a Surface Water Source or groundwater source under
the direct influence of surface water that operate for only part of the year
must conduct source water monitoring in accordance with 310 CMR 22.20G, but
with the following modifications:
1. Systems
must sample their source water only during the months that the plant operates
unless the Department specifies another monitoring period based on plant
operating practices.
2. Systems
with plants that operate less than six months per year and that monitor for
Cryptosporidium must collect at least six
Cryptosporidium samples per year during each of two years of
monitoring. Samples must be evenly spaced throughout the period the plant
operates.
(f)
1.
New Sources. A
system that begins using a New Source of Surface Water or groundwater under the
direct influence of surface water after the system is required to begin
monitoring under 310 CMR 22.20G(2)(c) must monitor the New Source on a schedule
the Department approves. Source water monitoring must meet the requirements of
310 CMR 22.20G. The system must also meet the bin classification and
Cryptosporidium treatment requirements of 310 CMR 22.20G(11)
and (12) or (13), as applicable, for the New Source on a schedule the
Department approves.
2. The
requirements of 310 CMR 22.20G(2)(f) apply to suppliers of water with a Surface
Water Source or groundwater source under the direct influence of surface water
that begin operation after the monitoring start date applicable to the system's
size under 310 CMR 22.20G(2)(c).
3.
The system must begin a second round of source water monitoring no later than
six years following initial bin classification under 310 CMR 22.20G(11) or
determination of the mean Cryptosporidium level under 310 CMR
22.20G(13), as applicable.
(g) Failure to collect any source water
sample required under 310 CMR 22.20G(2) in accordance with the sampling
schedule, sampling location, analytical method, approved laboratory, and
reporting requirements of 310 CMR 22.20G(3) through (7) is a monitoring
violation.
(h)
Grandfathering Monitoring Data. Systems may use
(grandfather) monitoring data collected prior to the applicable monitoring
start date in 310 CMR 22.20G(2)(c) to meet the initial source water monitoring
requirements in 310 CMR 22.20G(a). Grandfathered data may substitute for an
equivalent number of months at the end of the monitoring period. All data
submitted under 310 CMR 22.20G(2)(h) must meet the requirements in 310 CMR
22.20G(8).
(3)
Sampling Schedules.
(a) Systems required to conduct source water
monitoring under 310 CMR 22.20G(2) must submit a sampling schedule that
specifies the calendar dates when the system will collect each required sample.
1. Systems must submit sampling schedules no
later than three months prior to the applicable date listed in 310 CMR
22.20G(2)(c) for each round of required monitoring.
2.
a.
Systems serving at least 10,000 people must submit their sampling schedule for
the initial round of source water monitoring under 310 CMR 22.20G(2)(a) to EPA
electronically at https://intranet.epa.gov/lt2/ [File Link Not
Available].
b. If a system is
unable to submit the sampling schedule electronically, the system may use an
alternative approach for submitting the sampling schedule that EPA or the
Department approves.
3.
Systems serving fewer than 10,000 people must submit their sampling schedules
for the initial round of source water monitoring 310 CMR 22.20G(2)(a) to the
Department.
4. Systems must submit
sampling schedules for the second round of source water monitoring 310 CMR
22.20G(2)(b) to the Department.
5.
If the Department does not respond to a system regarding its sampling schedule,
the system must sample at the reported schedule.
(b) Systems must collect samples within two
days before or two days after the dates indicated in their sampling schedule
(
i.e., within a five-day period around the schedule date)
unless one of the conditions of 310 CMR 22.20G(3)(b)1. or 2. applies.
1. If an extreme condition or situation
exists that may pose danger to the sample collector, or that cannot be avoided
and causes the system to be unable to sample in the scheduled five-day period,
the system must sample as close to the scheduled date as is feasible unless the
Department approves an alternative sampling date. The system must submit an
explanation for the delayed sampling date to the Department concurrent with the
shipment of the sample to the laboratory.
2.
a. If a
system is unable to report a valid analytical result for a scheduled sampling
date due to equipment failure, loss of or damage to the sample, failure to
comply with the analytical method requirements, including the quality control
requirements in 310 CMR 22.20G(5), or the failure of an approved laboratory to
analyze the sample, then the system must collect a replacement
sample.
b. The system must collect
the replacement sample not later than 21 days after receiving information that
an analytical result cannot be reported for the scheduled date unless the
system demonstrates that collecting a replacement sample within this time frame
is not feasible or the Department approves an alternative resampling date. The
system must submit an explanation for the delayed sampling date to the
Department concurrent with the shipment of the sample to the
laboratory.
(c) Systems that fail to meet the criteria of
310 CMR 22.20G(3)(b) for any source water sample required under 310 CMR
22.20G(2) must revise their sampling schedules to add dates for collecting all
missed samples. Systems must submit the revised schedule to the Department for
approval prior to when the system begins collecting the missed
samples.
(4)
Sampling Locations.
(a) Systems required to conduct source water
monitoring under 310 CMR 22.20G(2) must collect samples for each plant that
treats a Surface Water Source, or a groundwater source under the direct
influence of surface water. Where multiple plants draw water from the same
influent, such as the same pipe or intake, the Department may approve one set
of monitoring results to be used to satisfy the requirements of 310 CMR
22.20G(2) for all plants.
(b)
1. Systems must collect source water samples
prior to chemical treatment, such as coagulants, oxidants and disinfectants,
unless the system meets the condition specified in 310 CMR
22.20G(4)(b)2.
2. The Department
may approve a system to collect a source water sample after chemical treatment.
To grant this approval, the Department will determine that collecting a sample
prior to chemical treatment is not feasible for the system and that the
chemical treatment is unlikely to have a significant adverse effect on the
analysis of the sample.
(c) Systems that recycle filter backwash
water must collect source water samples prior to the point of filter backwash
water addition.
(d)
Bank Filtration.
1.
Systems that receive Cryptosporidium treatment credit for Bank
Filtration under
310 CMR
22.20D(4)(b) or
22.20F(6)(c),
as applicable, must collect source water samples in the Surface Water prior to
Bank Filtration.
2. Systems that
use Bank Filtration as pretreatment to a Filtration plant must collect source
water samples from the well (i.e., after Bank Filtration). Use
of Bank Filtration during monitoring must be consistent with routine
operational practice. Systems collecting samples after a Bank Filtration
process may not receive treatment credit for the bank filtration under the
Massachusetts Drinking Water Guidelines and Policies, Appendix
N, Requirements for Microbial Toolbox Options for Meeting
Cryptosporidium Treatment Requirements under the Long Term 2
Enhanced Surface Water Treatment Rule for Public Water Systems.
(e)
Multiple
Sources. Systems with plants that use multiple water sources,
including multiple Surface Water Sources and blended Surface Water and
groundwater sources, must collect samples as specified in 310 CMR
22.20G(4)(e)1. or 2. The use of multiple sources during monitoring must be
consistent with routine operational practice.
1. If a sampling tap is available where the
sources are combined prior to treatment, systems must collect samples from the
tap.
2. If a sampling tap where the
sources are combined prior to treatment is not available, systems must collect
samples at each source near the intake on the same day and must follow either
310 CMR 22.20G(4)(e)2.a. or b. for sample analysis.
a. Systems may composite samples from each
source into one sample prior to analysis. The volume of sample from each source
must be weighted according to the proportion of the source in the total plant
flow at the time the sample is collected.
b. Systems may analyze samples from each
source separately and calculate a weighted average of the analysis results for
each sampling date. The weighted average must be calculated by multiplying the
analysis result for each source by the fraction the source contributed to total
plant flow at the time the sample was collected and then summing these
values.
(f)
Additional Requirements. Systems must submit a
description of their sampling location(s) to the Department at the same time as
the sampling schedule required under 310 CMR 22.20G(3). This description must
address the position of the sampling location in relation to the system's water
source(s) and treatment processes, including pretreatment, points of chemical
treatment, and filter backwash recycle. If the Department does not respond to a
system regarding sampling location(s), the system must sample at the reported
location(s).
(5)
Analytical Methods.
(a)
Cryptosporidium. Systems must analyze
for
Cryptosporidium using
Method 1623: Cryptosporidium
and Giardia in Water by Filtration/IMS/FA, 2005, United States
Environmental Protection Agency, EPA-815-R-05-002 or
Method 1622:
Cryptosporidium in Water by Filtration/IMS/FA, 2005, United States
Environmental Protection Agency, EPA-815-R-05-001, which are incorporated by
reference.
1. Systems must analyze at least a
10 L sample or a packed pellet volume of at least 2 mL as generated by the
methods listed in 310 CMR 22.20G(5)(a). Systems unable to process a 10 L sample
must analyze as much sample volume as can be filtered by two filters approved
by EPA and the Department for the methods listed in 310 CMR 22.20G(5)(a), up to
a packed pellet volume of at least 2 mL.
2. Matrix spike (MS) samples, as required by
the methods in 310 CMR 22.20G(5)(a), must be spiked and filtered by a
laboratory approved for Cryptosporidium analysis under 310 CMR
22.20G(6). If the volume of the MS sample is greater than 10 L, the system may
filter all but 10 L of the MS sample in the field, and ship the filtered sample
and the remaining 10 L of source water to the laboratory. In this case, the
laboratory must spike the remaining 10 L of water and filter it through the
filter used to collect the balance of the sample in the field.
3. Flow cytometer-counted spiking suspensions
must be used for MS samples and ongoing precision and recovery (OPR)
samples.
(b)
E. coli. Systems must use methods for
enumeration of
E. coli in source water approved in accordance
with
310 CMR
22.26(3)(c).
1. The time from sample collection to
initiation of analysis may not exceed 30 hours unless the system meets the
condition of 310 CMR 22.20G(5)(b)2.
2. The Department may approve on a
case-by-case basis the holding of an E. coli sample for up to
48 hours between sample collection and initiation of analysis if the Department
determines that analyzing an E. coli sample within 30 hours is
not feasible. E. coli samples held between 30 to 48 hours must
be analyzed by the Colilert reagent version of Standard Method 9223B as listed
in
310 CMR
22.26(3)(c).
3. Systems must maintain samples between
0°C and 10°C during storage and transit to the laboratory.
(c)
Turbidity. Systems must use methods for Turbidity
measurement approved in
310 CMR
22.20A(5)(a)1.
(6)
Approved
Laboratories.
(a)
Cryptosporidium. Systems must have
Cryptosporidium samples analyzed by a laboratory that is
approved under EPA's Laboratory Quality Assurance Evaluation Program for
Analysis of Cryptosporidium in Water or a laboratory that has
been certified for Cryptosporidium analysis by an equivalent
Department laboratory certification program.
(b)
E.
coli. Any laboratory certified by the EPA, the National
Environmental Laboratory Accreditation Conference or the Department for total
coliform or fecal coliform analysis under
310 CMR 22.20A(5)
is approved for E. coli
analysis under 310 CMR 22.20G when the laboratory uses the same technique for
E. coli that the laboratory uses for
310 CMR
22.20A(5).
(c)
Turbidity.
Measurements of Turbidity must be made by a party approved by the
Department.
(7)
Reporting Source Water Monitoring Results.
(a) Systems must report results from the
source water monitoring required under 310 CMR 22.20G(2) no later than ten days
after the end of the first month following the month when the sample is
collected.
(b) All systems serving
at least 10,000 people must report the results from the initial source water
monitoring required under 310 CMR 22.20G(2)(a) to EPA electronically at
https://intranet.epa.gov/lt2/ [File Link Not Available]. If a system is unable
to report monitoring results electronically, the system may use an alternative
approach for reporting monitoring results that EPA approves.
(c) Systems serving fewer than 10,000
individuals must report results from the initial source water monitoring
required under 310 CMR 22.20G(2)(a) to the Department.
(d) All systems must report results from the
second round of source water monitoring required under 310 CMR 22.20G(2)(b) to
the Department.
(e) Systems must
report the applicable information in paragraphs 310 CMR 22.20G(7)(e)1. and 2.
for the source water monitoring required under 310 CMR 22.20G(2).
1. Systems must report the following data
elements for each
Cryptosporidium analysis:
a. PWS ID;
b. Facility ID;
c. Sample collection date;
d. Sample type (field or matrix
spike);
e. Sample volume filtered
(L), to nearest 1/4 L;
f. Was
100% of filtered volume examined; and
g. Number of
oocysts
counted.
i. For matrix spike samples, systems
must also report the sample volume spiked and estimated number of
oocysts spiked. These data are not required for field samples.
ii. For samples in which less than
10 L is filtered or less than 100% of the sample volume is examined, systems
must also report the number of filters used and the packed pellet volume.
iii. For samples in which less
than 100% of sample volume is examined, systems must also report the volume of
resuspended concentrate and volume of this resuspension processed through
immunomagnetic separation.
2. Systems must report the following data
elements for each
E. coli analysis:
a. PWS ID;
b. Facility ID;
c. Sample collection date;
d. Analytical method number;
e. Method type;
f. Source type (flowing stream,
Lake/Reservoir, GWUDI);
g.
E. coli/100 mL; and
h. Turbidity.1
1 Systems serving fewer than 10,000
individuals that are not required to monitor for Turbidity as specified in 310
CMR 22.20G(2) are not required to report Turbidity with their E. coli
results.
(8)
Grandfathering Previously
Collected Data.
(a)
1. Systems may comply with the initial source
water monitoring requirements of 310 CMR 22.20G(2)(a) by grandfathering sample
results collected before the system is required to begin monitoring
(i.e., previously collected data). To be grandfathered, the
sample results and analysis must meet the criteria in 310 CMR 22.20G(8) and the
Department must approve.
2. A
filtered system may grandfather Cryptosporidium samples to
meet the requirements of 310 CMR 22.20G(2)(a) when the system does not have
corresponding E. coli and Turbidity samples. A system that
grandfathers Cryptosporidium samples without E. coli
and Turbidity samples is not required to collect E. coli
and Turbidity samples when the system completes the requirements for
Cryptosporidium monitoring under 310 CMR
22.20G(2)(a).
(b)
E. coli Sample
Analysis. The analysis of E. coli samples must
meet the analytical method and approved laboratory requirements of 310 CMR
22.20G(5) through (6).
(c)
Cryptosporidium Sample
Analysis. The analysis of
Cryptosporidium samples
must meet the criteria in 310 CMR 22.20G(8)(c).
1. Laboratories analyzed
Cryptosporidium samples using one of the analytical methods in
310 CMR 22.20G(8)(c)1.a. through f., which are incorporated by reference.
a. Method 1623: Cryptosporidium
and Giardia in Water by Filtration/IMS/ FA, 2005,
United States Environmental Protection Agency, EPA-815-R-05-002.
b. Method 1622: Cryptosporidium
in Water by Filtration/IMS/FA, 2005, United States Environmental
Protection Agency, EPA-815-R-05-001.
c. Method 1623: Cryptosporidium
and Giardia in Water by Filtration/IMS/ FA, 2001,
United States Environmental Protection Agency, EPA-821-R-01-025.
d. Method 1622: Cryptosporidium
in Water by Filtration/IMS/FA, 2001, United States Environmental
Protection Agency, EPA-821--R-01-026.
e. Method 1623: Cryptosporidium
and Giardia in Water by Filtration/IMS/ FA, 1999,
United States Environmental Protection Agency, EPA-82 1-R-99-006.
f. Method 1622:
Cryptosporidium in Water by
Filtration/IMS/FA, 1999, United Departments Environmental Protection Agency,
EPA-821-R-99-001.
2. For
each Cryptosporidium sample, the laboratory analyzed at least
10 L of sample or at least 2 mL of packed pellet or as much volume as could be
filtered by two filters that EPA and the Department approved for the methods
listed in 310 CMR 22.20G(8)(c)1.
(d)
Sampling
Location. The sampling location must meet the conditions as
specified in 310 CMR 22.20G(4).
(e)
Sampling Frequency.
Cryptosporidium
samples were collected no less frequently than each calendar month on a regular
schedule, beginning no earlier than January 1999. Sample collection intervals
may vary for the conditions specified in 310 CMR 22.20G(3)(b)1. and 2. if the
system provides documentation of the condition when reporting monitoring
results.
1. The Department may approve
grandfathering of previously collected data where there are time gaps in the
sampling frequency if the system conducts additional monitoring the Department
specifies to ensure that the data used to comply with the initial source water
monitoring requirements of 310 CMR 22.20G(2)(a) are seasonally representative
and unbiased.
2. Systems may
grandfather previously collected data where the sampling frequency within each
month varied. If the Cryptosporidium sampling frequency
varied, systems must follow the monthly averaging procedure in 310 CMR
22.20G(11)(b)5. or 310 CMR 22.20G(13)(a)3., as applicable, when calculating the
bin classification for filtered systems or the mean Cryptosporidium
concentration for unfiltered systems.
(f)
Reporting Monitoring Results
for Grandfathering. Systems that request to grandfather previously
collected monitoring results must report the following information by the
applicable dates listed in 310 CMR 22.20G(3).
1. Systems must report that they intend to
submit previously collected monitoring results for grandfathering. This report
must specify the number of previously collected results the system will submit,
the dates of the first and last sample, and whether a system will conduct
additional source water monitoring to meet the requirements of 310 CMR
22.20G(2)(a). Systems must report this information no later than the date
required by the sampling schedule under 310 CMR 22.20G(3).
2. Systems must report previously collected
monitoring results for grandfathering, along with the associated documentation
listed in 310 CMR 22.20G(8)(f)(2) a. through d., no later than two months after
the applicable date listed in 310 CMR 22.20G(2)(c).
a. For each sample result, systems must
report the applicable data elements in 310 CMR 22.20G(7).
b. Systems must certify that the reported
monitoring results include all results the system generated during the time
period beginning with the first reported result and ending with the final
reported result. This applies to samples that were collected from the sampling
location specified for source water monitoring under 310 CMR 22.20G, not
spiked, and analyzed using the laboratory's routine process for the analytical
methods listed in 310 CMR 22.20G.
c. Systems must certify that the samples were
representative of a plant's source water(s) and the source water(s) have not
changed. Systems must report a description of the sampling location(s), which
must address the position of the sampling location in relation to the system's
water source(s) and treatment processes, including points of chemical addition
and filter backwash recycle.
d. For
Cryptosporidium samples, the laboratory or laboratories that
analyzed the samples must provide a letter certifying that the quality control
criteria specified in the methods listed in 310 CMR 22.20G(8)(c)1. were met for
each sample batch associated with the reported results. Alternatively, the
laboratory may provide bench sheets and sample examination report forms for
each field, matrix spike, IPR, OPR, and method blank sample associated with the
reported results.
(g) If the Department determines that a
previously collected data set submitted for grandfathering was generated during
source water conditions that were not normal for the system, such as a drought,
the Department may disapprove the data. Alternatively, the Department may
approve the previously collected data if the system reports additional source
water monitoring data, as determined by the Department, to ensure that the data
set used under 310 CMR 22.20G(11) or (13) represents average source water
conditions for the system.
(h) If a
system submits previously collected data that fully meet the number of samples
required for initial source water monitoring under 310 CMR 22.20G(2)(a) and
some of the data are rejected due to not meeting the requirements of 310 CMR
22.20G(8), systems must conduct additional monitoring to replace rejected data
on a schedule the Department approves. Systems are not required to begin this
additional monitoring until two months after notification that data have been
rejected and additional monitoring is necessary.
(9)
Requirements When Making a
Significant Change in Disinfection Practice.
(a) Following the completion of initial
source water monitoring under 310 CMR 22.20G(2)(a), a system that plans to make
a significant change to its Disinfection practice, as defined in 310 CMR
22.20G(9)(b), must develop Disinfection Profiles and calculate Disinfection
benchmarks for
Giardia lamblia and Viruses as described in 310
CMR 22.20G(10). Prior to changing the Disinfection practice, the system must
notify the Department and must include in this notice the information in 310
CMR 22.20G(9)(a)1. through 3.
1. A completed
Disinfection Profile and Disinfection benchmark for Giardia lamblia
and Viruses as described in 310 CMR 22.20G(10).
2. A description of the proposed change in
Disinfection practice.
3. An
analysis of how the proposed change will affect the current level of
Disinfection.
(b)
Significant changes to Disinfection practice are defined as follows:
1. Changes to the point of
Disinfection;
2. Changes to the
Disinfectant(s) used in the treatment plant;
3. Changes to the Disinfection process;
or
4. Any other modification
identified by the Department as a significant change to Disinfection
practice.
(10)
Developing the Disinfection
Profile and Benchmark.
(a)
Systems required to develop Disinfection Profiles under 310 CMR 22.20G(9) must
follow the requirements of 310 CMR 22.20G(10). Systems must monitor at least
weekly for a period of 12 consecutive months to determine the total log
inactivation for Giardia lamblia and Viruses. If systems
monitor more frequently, the monitoring frequency must be evenly spaced.
Systems that operate for fewer than 12 months per year must monitor weekly
during the period of operation. Systems must determine log inactivation for
Giardia lamblia through the entire plant, based on CT99.9
values in
310 CMR
22.20A(5)(b): Tables
1.1 through 1.6, 2.1, and 3.1 as
applicable. Systems must determine log inactivation for Viruses through the
entire treatment plant based on a protocol approved by the
Department.
(b) Systems with a
single Point of Disinfectant Application prior to the entrance to the
Distribution System must conduct the monitoring in 310 CMR 22.20G(10)(b)1.
through 4. Systems with more than one Point of Disinfectant Application must
conduct the monitoring in 310 CMR 22.20G(10)(b)1. through 4. for each
Disinfection segment. Systems must monitor the parameters necessary to
determine the total inactivation ratio, using analytical methods in
310 CMR
22.20A(5)(a).
1. For systems using a Disinfectant other
than UV, the temperature of the disinfected water must be measured at each
Residual Disinfectant Concentration Sampling Point during peak hourly flow or
at an alternative location approved by the Department.
2. For systems using chlorine, the pH of the
disinfected water must be measured at each chlorine Residual Disinfectant
Concentration Sampling Point during peak hourly flow or at an alternative
location approved by the Department.
3. The Disinfectant Contact Time(s) (t) must
be determined during peak hourly flow.
4. The Residual Disinfectant Concentration(s)
(C) of the water before or at the first customer and prior to each additional
Point of Disinfectant Application must be measured during peak hourly
flow.
(c) In
lieu of conducting new monitoring under 310 CMR 22.20G(10)(b),
systems may elect to meet the requirements of 310 CMR 22.20G(10)(c)1. or 2.
1. Systems that have at least one year of
existing data that are substantially equivalent to data collected under the
provisions of 310 CMR 22.20G(10)(b) may use these data to develop Disinfection
Profiles as specified in 310 CMR 22.20G(10) if the system has neither made a
significant change to its treatment practice nor changed sources since the data
were collected. Systems may develop Disinfection Profiles using up to three
years of existing data.
2. Systems
may use Disinfection Profile(s) developed under
310 CMR
22.20D(3) or (4) in
lieu of developing a new profile if the system has neither
made a significant change to its treatment practice nor changed sources since
the profile was developed. Systems that have not developed a Virus profile
under
310 CMR
22.20D(3) or
22.20F(4)
must develop a Virus profile using the same
monitoring data on which the Giardia lamblia profile is
based.
(d) Systems must
calculate the total inactivation ratio for
Giardia lamblia as
specified in 310 CMR 22.20G(10)(d)1. through 3.
1. Systems using only one Point of
Disinfectant Application may determine the total inactivation ratio for the
Disinfection segment based on either of the methods in 310 CMR 22.2G(10)(d)1.a.
or b.
a. Determine one inactivation ratio
(CTcalc/CT99.9) before or at the first customer during
peak hourly flow.
b. Determine
successive CTcalc/ CT99.9 values, representing
sequential inactivation ratios, between the Point of Disinfectant Application
and a point before or at the first customer during peak hourly flow. The system
must calculate the total inactivation ratio by determining
(CTcalc/CT99.9) for each sequence and then adding the
(CTcalc/ CT99.9) values together to determine ( G
(CTcalc/CT99.9)).
2. Systems using more than one Point of
Disinfectant Application before the first customer must determine the CT value
of each Disinfection segment immediately prior to the next Point of
Disinfectant Application, or for the final segment, before or at the first
customer, during peak hourly flow. The (CTcalc/ CT99.9)
value of each segment and ((CTcalc/CT99.9)) must be
calculated using the method in 310 CMR 22.20G(10)(d)1.b.
3. The system must determine the total logs
of inactivation by multiplying the value calculated in 310 CMR 22.20G(10)(d)1.
or 2. by 3.0.
4. Systems must
calculate the log of inactivation for Viruses using a protocol approved by the
Department.
(e) Systems
must use the procedures specified in 310 CMR 22.20G(10)(e)1. and 2. to
calculate a Disinfection benchmark.
1. For
each year of profiling data collected and calculated under 310 CMR
22.20G(10)(a) through (d), systems must determine the lowest mean monthly level
of both Giardia lamblia and Virus inactivation. Systems must
determine the mean Giardia lamblia and Virus inactivation for
each calendar month for each year of profiling data by dividing the sum of
daily or weekly Giardia lamblia and Virus log inactivation by
the number of values calculated for that month.
2. The Disinfection benchmark is the lowest
monthly mean value (for systems with one year of profiling data) or the mean of
the lowest monthly mean values (for systems with more than one year of
profiling data) of Giardia lamblia and Virus log inactivation
in each year of profiling data.
(11)
Bin Classification for
Filtered Systems.
(a) Following
completion of the initial round of source water monitoring required under 310
CMR 22.20G(2)(a), filtered systems must calculate an initial
Cryptosporidium bin concentration for each plant for which
monitoring was required. Calculation of the bin concentration must use the
Cryptosporidium results reported under 310 CMR 22.20G(2)(a)
and must follow the procedures in 310 CMR 22.20G(11)(b)1. through 5.
(b)
1. For
systems that collect a total of at least 48 samples, the bin concentration is
equal to the arithmetic mean of all sample concentrations.
2. For systems that collect a total of at
least 24 samples, but not more than 47 samples, the bin concentration is equal
to the highest arithmetic mean of all sample concentrations in any 12
consecutive months during which Cryptosporidium samples were
collected.
3. For systems that
serve fewer than 10,000 people and monitor for Cryptosporidium
for only one year (i.e., collect 24 samples in 12
months), the bin concentration is equal to the arithmetic mean of all sample
concentrations.
4. For systems with
plants operating only part of the year that monitor fewer than 12 months per
year under 310 CMR 22.20G(2)(e) the bin concentration is equal to the highest
arithmetic mean of all sample concentrations during any year of
Cryptosporidium monitoring.
5. If the monthly Cryptosporidium
sampling frequency varies, systems must first calculate a monthly
average for each month of monitoring. Systems must then use these monthly
average concentrations, rather than individual sample concentrations, in the
applicable calculation for bin classification in 310 CMR 22.20G(11)(b)1.
through 4.
(c) Filtered
systems must determine their initial bin classification from 310 CMR 22.20G:
Table 2 and using the
Cryptosporidium bin
concentration calculated under 310 CMR 22.20G(11)(a) and (b):
310 CMR 22.20G: Table 2
BIN CLASSIFICATION TABLE FOR FILTERED SYSTEMS
For Systems that are:
|
With a Cryptosporidium bin
concentration of ...1
|
The bin classification is...
|
Required to monitor for Cryptosporidium
under 310 CMR 22.20G(2)
|
Cryptosporidium <0.075
oocysts/L
|
Bin 1
|
0.075
oocysts/L<Cryptosporidium <1.0
oocysts/L
|
Bin 2
|
1.0 oocysts/L<
Cryptosporidium <3.0 oocysts/L
|
Bin 3
|
Cryptosporidium >=3.0
oocysts/L
|
Bin 4
|
Serving fewer than 10,000 people and NOT required to
monitor for Cryptosporidium under 310 CMR
22.20G(2)(a)4.
|
N/A
|
Bin 1
|
1 Based on calculations in 310 CMR
22.20G(11)(a) or (d), as applicable.
(d) Following completion of the second round
of source water monitoring required under 310 CMR 22.20G(2)(b) filtered systems
must recalculate their Cryptosporidium bin concentration using
the Cryptosporidium results reported under 310 CMR
22.20G(7)(d) and following the procedures in 310 CMR 22.20G(11)(b)1. through 4.
Systems must then redetermine their bin classification using this bin
concentration and the table in 310 CMR 22.20G(11)(c).
(e)
1.
Filtered systems must report their initial bin classification under 310 CMR
22.20G(11)(c) to the Department for approval no later than six months after the
system is required to complete initial source water monitoring based on the
schedule in 310 CMR 22.20G(2)(c).
2. Systems must report their bin
classification under 310 CMR 22.20G(11)(d) to the Department for approval no
later than six months after the system is required to complete the second round
of source water monitoring based on the schedule in 310 CMR
22.20G(2)(c).
3. The bin
classification report to the Department must include a summary of source water
monitoring data and the calculation procedure used to determine bin
classification.
(f)
Failure to comply with the conditions of 310 CMR 22.20G(11)(e) is a violation
of the Treatment Technique requirement.
(12)
Filtered System Additional
Cryptosporidium Treatment Requirements.
(a) Filtered systems must provide the level
of additional treatment for
Cryptosporidium specified in 310
CMR 22.20G(12)(a) based on their bin classification as determined under 310 CMR
22.20G(11) and according to the schedule in 310 CMR 22.20G(14).
310 CMR 22.20G: Table 3
FILTERED SYSTEM ADDITIONAL CRYPTOSPORIDIUM
TREATMENT REQUIREMENTS
If the system bin classification is ...
|
And the system uses the following Filtration
treatment in full compliance with
310 CMR
22.20A,
310 CMR
22.20D, and
310 CMR
22.20F (as applicable), then the additional
Cryptosporidium treatment requirements are ...
|
Conventional Filtration treatment (including
softening)
|
Direct Filtration
|
Slow Sand or Diatomaceous Earth Filtration
|
Alternative Filtration technologies
|
Bin 1
|
No additional treatment
|
No additional treatment
|
No additional treatment
|
No additional treatment
|
Bin 2
|
1-log treatment
|
1.5-log treatment
|
1-log treatment
|
-1
|
Bin 3
|
2-log treatment
|
2.5-log treatment
|
2-log treatment
|
-2
|
Bin 4
|
2.5-log treatment
|
3-log treatment
|
2.5-log treatment
|
-3
|
1 As determined by the Department
such that the total Cryptosporidium removal and inactivation
is at least 4.0-log.
2 As determined by the Department
such that the total Cryptosporidium removal and inactivation
is at least 5.0-log.
3 As determined by the Department
such that the total Cryptosporidium removal and inactivation
is at least 5.5-log.
(b)
1. Filtered systems must use one or more of
the treatment and management options listed in 310 CMR 22.20G(18) to comply
with the additional Cryptosporidium treatment required in 310
CMR 22.20G(12)(a).
2. Systems
classified in Bin 3 and Bin 4 must achieve at least 1-log of the additional
Cryptosporidium treatment required under 310 CMR 22.20G(12)(a)
using either one or a combination of the following: Bag Filters, Bank
Filtration, Cartridge Filters, chlorine dioxide, membranes, ozone, or UV, in
accordance with 310 CMR 22.20G(19) through (23).
(c) Failure by a system in any month to
achieve treatment credit by meeting criteria in 310 CMR 22.20G(19) through
(23), that is at least equal to the level of treatment required in 310 CMR
22.20G(12)(a) is a violation of the Treatment Technique requirement.
(d) If the Department determines during a
Sanitary Survey or an equivalent source water assessment that after a system
completed the monitoring conducted under 310 CMR 22.20G(2)(a) or (b),
significant changes occurred in the system's Watershed that could lead to
increased contamination of the source water by
Cryptosporidium, the system must take actions specified by the
Department to address the contamination. These actions may include additional
source water monitoring and/or implementing microbial toolbox options in
accordance with 310 CMR 22.20G(18) through (23).
(13)
Unfiltered System
Cryptosporidium Treatment Requirements.
(a)
Determination of Mean
Cryptosporidium Level.
1. Following completion of the initial source
water monitoring required under 310 CMR 22.20G(2)(a) unfiltered systems must
calculate the arithmetic mean of all Cryptosporidium sample
concentrations reported under 310 CMR 22.20G(2)(a). Systems must report this
value to the Department for approval no later than six months after the month
the system is required to complete initial source water monitoring based on the
schedule in 310 CMR 22.20G(2)(c).
2. Following completion of the second round
of source water monitoring required under 310 CMR 22.20G(2)(b) unfiltered
systems must calculate the arithmetic mean of all Cryptosporidium
sample concentrations reported under 310 CMR 22.20G(2)(b). Systems
must report this value to the Department for approval no later than six months
after the month the system is required to complete the second round of source
water monitoring based on the schedule in 310 CMR 22.20G(2)(c).
3. If the monthly Cryptosporidium
sampling frequency varies, systems must first calculate a monthly
average for each month of monitoring. Systems must then use these monthly
average concentrations, rather than individual sample concentrations, in the
calculation of the mean Cryptosporidium level in 310 CMR
22.20G(13)(a)1. or 2.
4. The report
to the Department of the mean Cryptosporidium levels
calculated under 310 CMR 22.20G(13)(a)1. and 2. must include a summary of the
source water monitoring data used for the calculation.
5. Failure to comply with the conditions of
310 CMR 22.20G(13)(a) is a violation of the Treatment Technique
requirement.
(b)
Cryptosporidium
Inactivation Requirements.
Unfiltered systems must provide the level of inactivation for
Cryptosporidium specified in 310 CMR 22.20G(13)(b)1. and 2.,
based on their mean
Cryptosporidium levels as determined under
310 CMR 22.20G(13)(a) and according to the schedule in 310 CMR 22.20G(14).
1. Unfiltered systems with a mean
Cryptosporidium level of 0.01 oocysts/L or
less must provide at least 2-log Cryptosporidium
inactivation.
2. Unfiltered systems
with a mean Cryptosporidium level of greater than 0.01
oocysts/L must provide at least 3-log
Cryptosporidium inactivation.
(c)
Inactivation Treatment
Technology Requirements. Unfiltered systems must use chlorine
dioxide, ozone, or UV; in accordance with 310 CMR 22.20G(23); in order to meet
the
Cryptosporidium inactivation requirements of 310 CMR
22.20G(13).
1. Systems that use chlorine
dioxide or ozone and fail to achieve the Cryptosporidium
inactivation required in 310 CMR 22.20G(13)(b) on more than one day in the
calendar month are in violation of the Treatment Technique
requirement.
2. Systems that use UV
light, and fail to achieve the Cryptosporidium inactivation
required in 310 CMR 22.20G(13)(b) by meeting the criteria in 310 CMR
22.20G(23)(b)1.d., are in violation of the Treatment Technique
requirement.
(d)
Use of Two Disinfectants. Unfiltered systems must meet
the combined Cryptosporidium inactivation requirements of 310
CMR 22.20G(13) and Giardia lamblia and Virus inactivation
requirements of
310 CMR 22.20A(3)(a)
using a minimum of two Disinfectants, and
each of two Disinfectants must separately achieve the total inactivation
required for Cryptosporidium, Giardia
lamblia, or Viruses.
(14)
Schedule for Compliance with
Cryptosporidium Treatment Requirements.
(a) Following initial bin classification
under 310 CMR 22.20G(11)(c), filtered systems must provide the level of
treatment for Cryptosporidium required under 310 CMR
22.20G(12) according to the schedule in 310 CMR 22.20G(14)(c).
(b) Following initial determination of the
mean Cryptosporidium level under 310 CMR 22.20G(13)(a)1.,
unfiltered systems must provide the level of treatment for
Cryptosporidium required under 310 CMR 22.20G(13) according to
the schedule in 310 CMR 22.20G(14)(c).
(c)
Cryptosporidium
Treatment Compliance Dates.
310 CMR 22.20G: Table 4
Cryptosporidium TREATMENT COMPLIANCE DATES
TABLE
Systems that serve ...
|
Must comply with Cryptosporidium
treatment requirements no later than...*
|
(1) At least 100,000 individuals
|
April 1, 2012
|
(2) From 50,000 to 99,999 individuals
|
October 1, 2012
|
(3) From 10,000 to 49,999 individuals
|
October 1, 2013
|
(4) Fewer than 10,000 individuals
|
October 1, 2014
|
* The Department may allow up to an additional two years for
complying with the treatment requirement for systems making capital
improvements.
(d) If the
bin classification for a filtered system changes following the second round of
source water monitoring, as determined under 310 CMR 22.20G(11)(d), the system
must provide the level of treatment for Cryptosporidium
required under 310 CMR 22.20G(12) on a schedule the Department
approves.
(e) If the mean
Cryptosporidium level for an unfiltered system changes
following the second round of monitoring, as determined under 310 CMR
22.20G(13)(a)2. and if the system must provide a different level of
Cryptosporidium treatment under 310 CMR 22.20G(13) due to this
change, the system must meet this treatment requirement on a schedule the
Department approves.
(15)
Requirements for Uncovered
Finished Water Storage Facilities.
(a) Systems using uncovered finished water
storage facilities must comply with the conditions of 310 CMR
22.20G(15).
(b) Systems must notify
the Department of the use of each Uncovered Finished Water Storage Facility no
later than April 1, 2008.
(c)
Systems must meet the conditions of 310 CMR 22.20G(15)(c)1. or 2. for each
Uncovered Finished Water Storage Facility or be in compliance with a
Department-approved schedule to meet these conditions no later than April 1,
2009.
1. Systems must cover any Uncovered
Finished Water Storage Facility.
2.
Systems must treat the discharge from the Uncovered Finished Water Storage
Facility to the Distribution System to achieve inactivation and/or removal of
at least 4-log Virus, 3-log Giardia lamblia, and 2-log
Cryptosporidium using a protocol approved by the
Department.
(d) Failure
to comply with the requirements of 310 CMR 22.20G(15) is a violation of the
Treatment Technique requirement.
(16)
Reporting
Requirements.
(a) Systems must
report sampling schedules under 310 CMR 22.20G(3) and source water monitoring
results under 310 CMR 22.20G(7) unless they notify the Department that they
will not conduct source water monitoring due to meeting the criteria of 310 CMR
22.20G(2)(d).
(b) Systems must
report the use of uncovered finished water storage facilities to the Department
as described in 310 CMR 22.20G(15).
(c) Filtered systems must report their
Cryptosporidium bin classification as described in 310 CMR
22.20G(11).
(d) Unfiltered systems
must report their mean source water Cryptosporidium level as
described in 310 CMR 22.20G(13).
(e) Systems must report Disinfection Profiles
and benchmarks to the Department as described in 310 CMR 22.20G(9) through (10)
prior to making a significant change in disinfection practice.
(f) Systems must report to the Department in
accordance with the following table for any microbial toolbox options used to
comply with treatment requirements under 310 CMR 22.20G(12) or (13).
Alternatively, the Department may approve a system to certify operation within
required parameters for treatment credit rather than reporting monthly
operational data for toolbox options.
310 CMR 22.20G: Table 5
MICROBIAL TOOLBOX REPORTING REQUIREMENTS
Toolbox option
|
Systems must submit the following information
|
On the following schedule
|
(1) Watershed control program.
|
(i) Notice of intention to develop a new or continue
an existing watershed control program...
(ii) Watershed control plan...
(iii) Annual watershed control program status
report......
(iv) Watershed sanitary survey
report..........
|
No later than two years before the applicable
treatment compliance date in 310 CMR 22.20G(14).
No later than one year before the applicable
treatment compliance date in 310 CMR 22.20G(14). Every 12 months, beginning one
year after the applicable treatment compliance date in 310 CMR
22.20G(14).
For Community Water Systems, every three years
beginning three years after the applicable treatment compliance date in 310 CMR
22.20G(14). For Noncommunity Water Systems, every five years beginning five
years after the applicable treatment compliance date in 310 CMR
22.20G(14).
|
(2) Alternative source/intake management
|
Verification that system has relocated the intake or
adopted the intake withdrawal procedure reflected in monitoring results.
|
No later than the applicable treatment compliance
date in 310 CMR 22.20G(14).
|
(3) Pre-sediments
|
Monthly verification of the following:
(i) Continuous basin operation
(ii) Treatment of 100% of the flow
(iii) Continuous addition of a coagulant
(iv) At least 0.5-log mean reduction of influent
Turbidity or compliance with alternative Department approved performance
criteria.
|
Monthly reporting within ten days following the month
in which the monitoring was conducted beginning on the applicable treatment
compliance date in 310 CMR 22.20G(14).
|
(4) Two-stage Lime Softening
|
Monthly verification of the following:
(i) Chemical addition and hardness precipitation
occurred in two separate and sequential softening stages prior to
Filtration
(ii) Both stages treated 100% of the plant
flow.
|
Monthly reporting within ten days following the month
in which the monitoring was conducted beginning on the applicable treatment
compliance date in 310 CMR 22.20G(14).
|
(5) Bank Filtration
|
(i) Initial demonstration of the following:
(A) Unconsolidated, predominantly sandy
aquifer
(B) Setback distance of at least 25 ft. (0.5-log
credit) or 50 ft. (1.0-log credit).
(ii) If monthly average of daily max Turbidity is
greater than one NTU then system must report result and submit an assessment of
the cause.
|
No later than the applicable treatment compliance
date in 310 CMR 22.20G(14).
Report within 30 days following the month in which
the monitoring was conducted, beginning on the applicable treatment compliance
date in 310 CMR 22.20G(14).
|
(6) Combined filter performance
|
Monthly verification of combined filter effluent
(CFE) Turbidity levels less than or equal to 0.15 NTU in at least 95% of the
four hour CFE measurements taken each month.
|
Monthly reporting within ten days following the month
in which the monitoring was conducted, beginning on the applicable treatment
compliance date in 310 CMR 22.20G(14).
|
(7) Individual filter performance
|
Monthly verification of the following:
(i) Individual filter effluent (IFE) Turbidity
levels less than or equal to 0.15 NTU in at least 95% of samples each month in
each filter.
(ii) No individual filter greater than 0.3 NTU in
two consecutive readings 15 minutes apart.
|
Monthly reporting within ten days following the month
in which the monitoring was conducted, beginning on the applicable treatment
compliance date in 310 CMR 22.20G(14).
|
(8) Demonstration of performance
|
(i) Results from testing following a
Department-approved protocol.
(ii) As required by the Department, monthly
verification of operation within conditions of Department approval for
demonstration of performance credit.
|
No later than the applicable treatment compliance
date in 310 CMR 22.20G(14).
Within ten days following the month in which
monitoring was conducted, beginning on the applicable treatment compliance date
in 310 CMR 22.20G(14).
|
(9) Bag Filters and Cartridge Filters
|
(i) Demonstration that the following criteria are
met:
(A) Process meets the definition of bag or cartridge
Filtration;
(B) Removal efficiency established through challenge
testing that meets criteria in 310 CMR 22.20G(22)(a).
(ii) Monthly verification that 100% of plant flow
was filtered.
|
No later than the applicable treatment compliance
date in 310 CMR 22.20G(14).
Within ten days following the month in which
monitoring was conducted, beginning on the applicable treatment compliance date
in 310 CMR 22.20G(14).
|
(10) Membrane Filtration
|
(i) Results of verification testing demonstrating the
following:
(A) Removal efficiency established through challenge
testing that meets criteria in 310 CMR 22.20G(22)(b).
(B) Integrity test method and parameters, including
resolution, sensitivity, test frequency, control limits, and associated
baseline.
(ii) Monthly report summarizing the following:
(A) All direct integrity tests above the control
limit;
(B) If applicable, any Turbidity or alternative
Department approved indirect integrity monitoring results triggering direct
integrity testing and the corrective action that was taken.
|
No later than the applicable treatment compliance
date in 310 CMR 22.20G(14).
Within ten days following the month in which
monitoring was conducted, beginning on the applicable treatment compliance date
in 310 CMR 22.20G(14).
|
(11) Second stage Filtration
|
Monthly verification that 100% of flow was filtered
through both stages and that first stage was preceded by Coagulation
step.
|
Within ten days following the month in which
monitoring was conducted, beginning on the applicable treatment compliance date
in 310 CMR 22.20G(14).
|
(12) Slow Sand Filtration (as secondary
filter)
|
Monthly verification that both a slow sand filter and
a preceding separate stage of Filtration treated 100% of flow from Surface
Water Sources or Groundwater Under the Direct Influence of Surface
Water.
|
Within ten days following the month in which
monitoring was conducted, beginning on the applicable treatment compliance date
in 310 CMR 22.20G(14).
|
(13) Chlorine dioxide
|
Summary of CT values for each day as described in 310
CMR 22.20G(23), as applicable.
|
Within ten days following the month in which
monitoring was conducted, beginning on the applicable treatment compliance date
in 310 CMR 22.20G(14).
|
(14) Ozone
|
Summary of CT values for each day as described in 310
CMR 22.20G(23), as applicable.
|
Within ten days following the month in which
monitoring was conducted, beginning on the applicable treatment compliance date
in 310 CMR 22.20G(14).
|
(15) UV
|
(i) Validation test results demonstrating operating
conditions that achieve required UV dose.
(ii) Monthly report summarizing the percentage of
water entering the Distribution System that was not treated by UV reactors
operating within validated conditions for the required dose as specified in 310
CMR 22.20G(23), as applicable.
|
No later than the applicable treatment compliance
date in 310 CMR 22.20G(14).
Within ten days following the month in which
monitoring was conducted, beginning on the applicable treatment compliance date
in 310 CMR 22.20G(14).
|
(17)
Recordkeeping
Requirements.
(a) Systems must
keep results from the initial round of source water monitoring under 310 CMR
22.20G(2)(a) and the second round of source water monitoring under 310 CMR
22.20G(2)(b) until three years after bin classification under 310 CMR
22.20G(11) for filtered systems or determination of the mean
Cryptosporidium level under 310 CMR 22.20G(11) for unfiltered
systems for the particular round of monitoring.
(b) Systems must keep any notification to the
Department that they will not conduct source water monitoring due to meeting
the criteria of 310 CMR 22.20G(2)(d) for three years.
(c) Systems must keep the results of
treatment monitoring associated with microbial toolbox options under 310 CMR
22.20G(18) through (23) and with uncovered finished water reservoirs under 310
CMR 22.20G(15), as applicable, for three years.
(18)
Microbial Toolbox Options
for Meeting Cryptosporidium Treatment
Requirements.
(a) A Public Water
System may receive the Cryptosporidium treatment credits
listed in 310 CMR22.20G(18)(b) Table 6, by meeting the
conditions for microbial toolbox options described in 310 CMR 22.20G(19)
through (23), provided however that unfiltered systems shall only be eligible
for Cryptosporidium treatment credits for the microbial
toolbox options described in 310 CMR 22.20G(23). A Supplier of Water may apply
these Cryptosporidium treatment credits to meet the treatment
requirements set forth in 310 CMR 22.20G(12) and (13), as applicable.
(b) The following table summarizes options in
the microbial toolbox set forth in 310 CMR 22.20G(19) through (23). In the
event of conflict between this table and the provisions of 310 CMR 22.20G(19)
through (23), the latter shall control.
310 CMR 22.20G: Table 6
MICROBIAL TOOLBOX SUMMARY TABLE: OPTIONS, TREATMENT CREDITS AND
CRITERIA
Toolbox Option
|
Log Credit
|
Cryptosporidium treatment
credit with design and implementation criteria
|
SOURCE PROTECTION AND MANAGEMENT TOOLBOX
OPTIONS
|
1. Watershed control program
|
0.5-log
|
For Department-approved program comprising required
elements, annual program status report to Department, and regular watershed
survey. Unfiltered systems are not eligible for credit. Specific criteria are
in 310 CMR 22.20G(19)(a).
|
2. Alternative source/intake management
|
No prescribed credit
|
Suppliers of Water may conduct simultaneous
monitoring for treatment bin classification at alternative intake locations or
under alternative intake management strategies. Specific criteria are in 310
CMR 22.20G(19)(b).
|
PRE FILTRATION TOOLBOX OPTIONS
|
3. Pre-sedimentation basin with Coagulation
|
0.5-log credit
|
Credit is given during any month that
pre-sedimentation basins achieve a monthly mean reduction of 0.5-log or greater
in Turbidity or alternative Department-approved performance criteria. To be
eligible, basins must be operated continuously with coagulant addition and all
plant flow must pass through basins. Specific criteria are in 310 CMR
22.20G(20)(a).
|
4. Two-stage Lime Softening
|
0.5-log credit
|
Credit for two-stage softening where chemical
addition and hardness precipitation occur in both stages. All plant flow must
pass through both stages. Single-stage softening is credited as equivalent to
conventional treatment. Specific criteria are in 310 CMR 22.20G(20)(b).
|
5. Bank Filtration
|
0.5-log
|
For 25-foot setback1.
Specific criteria are in 310 CMR 22.20G(20)(c).
|
1.0-log
|
For 50-foot setback1.
Specific criteria are in 310 CMR 22.20G(20)(c).
|
TREATMENT PERFORMANCE TOOLBOX
OPTIONS
|
6. Combined filter performance
|
0.5-log
|
Credit for combined filter effluent Turbidity less
than or equal to 0.15 NTU in at least 95% of measurements each month. Specific
criteria are in 310 CMR 22.20G(21)(a).
|
7. Individual filter performance
|
0.5-log
|
Credit is given in addition to 0.5-log combined
filter performance credit. Credit is given if individual filter effluent
Turbidity is less than or equal to 0.15 NTU in at least 95% of samples each
month in each filter and is never greater than 0.3 NTU in two consecutive
measurements in any filter. Specific criteria are in 310 CMR
22.20G(21)(b).
|
8. Demonstration of performance
|
Credit awarded
|
Credit awarded to unit process or treatment train
based on a demonstration to the Department with a Department-approved protocol.
Specific criteria are in 310 CMR 22.20G(21)(c).
|
ADDITIONAL FILTRATION TOOLBOX
OPTIONS
|
9. Bag or Cartridge Filters (individual
filters)
|
Up to 2-log
|
Up to 2-log credit based on the removal efficiency
demonstrated during challenge testing with a 1.0-log factor of safety. Specific
criteria are in 310 CMR 22.20G(22)(a).
|
10. Bag or Cartridge Filters (in series)
|
Up to 2.5-log
|
Up to 2.5-log credit based on the removal efficiency
demonstrated during challenge testing with a 0.5-log factor of safety. Specific
criteria are in 310 CMR 22.20G(22)(a).
|
11. Membrane Filtration
|
Log credit
|
Log credit equivalent to removal efficiency
demonstrated in challenge test for device if supported by direct integrity
testing. Specific criteria are in 310 CMR 22.20G(22)(b).
|
12. Second stage Filtration
|
0.5-log
|
0.5-log credit for second separate granular media
Filtration stage if treatment train includes Coagulation prior to first filter.
Specific criteria are in 310 CMR 22.20G(22)(c).
|
13. Slow sand filters
|
2.5-log
|
Credit as a secondary Filtration
step2. Specific criteria are in 310 CMR
22.20G(22)(d).
|
3.0-log
|
Credit as a primary Filtration process2.
Specific criteria are in 310 CMR 22.20G(22)(d).
|
INACTIVATION TOOLBOX OPTIONS
|
14. Chlorine dioxide
|
CT table
|
Log credit based on measured CT in relation to CT
table. Specific criteria in 310 CMR 22.20G(23)(a).
|
15. Ozone
|
CT table
|
Log credit based on measured CT in relation to CT
table. Specific criteria in 310 CMR 22.20G(23)(a).
|
16. UV
|
UV dose
|
Log credit based on validated UV dose in relation to
UV dose table; reactor validation testing required to establish UV dose and
associated operating conditions. Specific criteria in 310 CMR
22.20G(23)(b).
|
1 Aquifer must be unconsolidated
sand containing at least 10% fines; average Turbidity in wells must be less
than one NTU. Suppliers of Water using wells followed by Filtration when
conducting source water monitoring must sample the well to determine bin
classification and are not eligible for additional credit.
2 No prior chlorination for either
option.
(19)
Source Toolbox Components.
(a)
Watershed Control
Program. Suppliers of Water may apply for a 0.5-log
Cryptosporidium treatment credit for implementing an approved
watershed control program, in accordance with the following requirements:
1. provide advance written notice to the
Department of the intent to apply for the watershed control program credit no
later than two years prior to the treatment compliance date applicable to the
Public Water System in 310 CMR 22.20G(14), Schedule for Compliance with
Cryptosporidium Treatment requirements.
2. if no approved watershed control program
is in place, then submit to the Department for approval a proposed, written
watershed control plan no later than one year before the applicable treatment
compliance date in 310 CMR 22.20G(14). The availability of the watershed
control program treatment credit shall be contingent on Department approval of
the watershed control plan based on the inclusion and adequacy of all of the
following elements:
a. identification of an
area outside of which the likelihood of Cryptosporidium or
fecal contamination affecting the treatment Plant Intake is not significant
("area of influence"). The area of influence shall be evaluated in future
watershed surveys, as required in 310 CMR 22.20G(19)(a)5.b.
b. identification of both potential and
actual sources of Cryptosporidium contamination and an
assessment of the relative impact of these sources on the system's source water
quality.
c. an analysis of the
effectiveness and feasibility of control measures that could reduce
Cryptosporidium loading from sources of contamination to the
system's source water.
d. a
statement of goals and specific actions the Supplier of Water will undertake to
reduce source water
Cryptosporidium levels, including:
i. an explanation of how the actions are
expected to contribute to specific goals;
ii. identification of Watershed resource
requirements and commitments; and
iii. a schedule for implementing the
watershed control plan, once approved, including deadlines for completing
specific actions identified in the watershed control plan.
3. if an approved watershed
control program is in place as of January 5, 2006, then submit to the
Department for approval written documentation demonstrating that the existing
watershed control plan complies with the following:
a. the existing watershed control plan must
meet the above criteria listed in 310 CMR 22.20G(19)(a)2. in addition to any
criteria met in the existing approval; and
b. the existing watershed control plan must
specify ongoing and future actions that will reduce source water
Cryptosporidium levels.
4.
Credit in the Absence of
Department Response. If within 90 days of the Department's receipt
of a watershed control plan submitted under 310 CMR 22.20G(19)(a), the
Department does not respond to the Supplier of Water regarding approval of that
watershed control plan, and the Supplier of Water otherwise meets the
requirements of 310 CMR 22.20G(19)(a), the watershed control plan will be
considered approved and 0.5 log Cryptosporidium treatment
credit will be awarded, unless and until the Department subsequently withdraws
such approval.
5. Maintaining the
0.5-log
Cryptosporidium treatment credit for implementing an
approved watershed control program. In order to maintain a 0.5-log
Cryptosporidium treatment credit for implementing an approved
watershed control program, the Supplier of Water shall satisfy the following
requirements:
a. submit an annual watershed
control program status report to the Department. The annual watershed control
program status report shall describe the Supplier of Water's implementation of
the approved plan and assess the adequacy of the plan to meet its goals. It
must explain how the Supplier of Water is addressing any shortcomings in plan
implementation, including those previously identified by the Department or as
the result of the watershed survey conducted under 310 CMR 22.20G(19)(a)5.b.
The Supplier of Water shall also describe any significant changes that have
occurred in the Watershed since the last watershed sanitary survey. If a
Supplier of Water, based upon implementation of an approved watershed control
program, believes that a significant change to the approved watershed control
program is necessary, the Supplier of Water shall notify the Department in
writing of the changes it proposes to make to its approved watershed control
plan. Any such change to an approved watershed control plan shall be subject
to:
i. the Department's approval based upon
the plan's continued inclusion of and adequacy of the elements in 310 CMR
22.20G(19)(a)2.; and
ii. if any
change is likely to reduce the level of source water protection, the Supplier
of Water's notification shall include a plan and strategy indicating how the
proposed actions will mitigate this effect.
If within 60 days of the Department's receipt of a notification
of a change to an approved watershed control plan, the Department does not
respond to the Supplier of Water regarding approval of that change, and the
Supplier of Water otherwise meets the requirements of 310 CMR
22.20G(19)(a)5.a.i. and ii., then the changes to the approved watershed control
plan will be considered approved, unless and until the Department subsequently
withdraws such approval, based upon failure to meet such requirements.
b. undergo a watershed
sanitary survey every three years for Community Water Systems and every five
years for Non-community Water Systems which:
i. encompasses the area of influence
identified in the Department-approved watershed control plan;
ii. assesses the implementation of actions to
reduce source water Cryptosporidium levels; and
iii. identifies any significant New Sources
of Cryptosporidium;
iv. unless performed by the Department, is
performed by a qualified Person approved by the Department, based on
demonstrated knowledge and experience in:
A.
conducting watershed inspections and reviewing and assessing impacts to public
water supplies from existing land use practices, stormwater discharges, aquatic
and terrestrial invasive species, wildlife, public access and recreation,
agriculture, local zoning and non zoning controls;
B. recommending source water protection
measures to address impacts; and
C.
assisting with multi-town coordination and public education for water supply
protection.
Suppliers of Water shall submit the survey report to the
Department, unless the survey is performed by the Department. If the Department
determines that significant changes have occurred in the Watershed since the
previous watershed sanitary survey, the Department may establish an earlier
date than otherwise required in 310 CMR 22.20G(19)(a)5.b. by which Public Water
Systems shall undergo another watershed sanitary survey.
c. The Supplier of
Water shall make the watershed control plan, annual status reports, and
watershed sanitary survey reports available to the public in electronic or
printed form, upon request. These documents shall be in plain language and
include criteria by which to evaluate the success of the program in achieving
plan goals. A Supplier of Water may request in writing the Department's written
approval to withhold from the public portions of the annual status report,
watershed control plan, and watershed sanitary survey based on water supply
security considerations. Any such request must identify with specificity the
security considerations relevant to each portion proposed to be
withheld.
6. A Supplier
of Water's watershed control program treatment credit shall be subject to
withdrawal if the Department determines that the Supplier of Water is not
performing the approved watershed control plan.
(b)
Alternative
Source.
1. A Supplier of Water
may conduct source water monitoring that reflects a different intake location
(either in the same source or for an alternate source) or a different procedure
for the timing or level of withdrawal from the source (alternative source
monitoring). A Supplier of Water, subject to the Department's written approval,
may determine its bin classification under 310 CMR 22.20G(11) based on the
alternative source monitoring results.
2. If a Supplier of Water conducts
alternative source monitoring under 310 CMR 22.20G(19)(b), the Supplier of
Water shall also monitor its current Plant Intake concurrently, as described in
310 CMR 22.20G(2).
3. Alternative
source monitoring under 310 CMR 22.20G(19)(b)1. shall meet the requirements for
source monitoring to determine bin classification, as described in 310 CMR
22.20G(2) through (7). The Supplier of Water shall report the alternative
source monitoring results in writing to the Department, along with supporting
information documenting the operating conditions under which the samples were
collected.
4. If a Supplier of
Water determines its bin classification under 310 CMR 22.20G(11) using
alternative source monitoring results that reflect a different intake location
or a different procedure for managing the timing or level of withdrawal from
the source, the Supplier of Water shall relocate the intake or permanently
adopt the withdrawal procedure, as applicable, no later than the applicable
treatment compliance date in 310 CMR
22.20G(14)(c).
(20)
Pre-filtration Treatment
Toolbox Components.
(a)
Pre-sedimentation. A Supplier of Water using
Pre-sedimentation, subject to the Department's review and written approval,
shall receive a 0.5-log
Cryptosporidium treatment credit for
any month the Public Water System meets the following criteria:
1. the Pre-sedimentation is in continuous
operation and treats the entire plant flow taken from a Surface Water Source or
a Groundwater under the Direct Influence of Surface Water source;
2. the Supplier of Water continuously adds a
coagulant to the Pre-sedimentation basin; and
3. the Pre-sedimentation basin achieves the
following performance criteria:
a.
demonstrates at least 0.5-log mean reduction of influent Turbidity. This
reduction must be determined using daily Turbidity measurements in the
Pre-sedimentation influent and effluent and must be calculated as follows:
log10(monthly mean of daily influent Turbidity) - log10(monthly mean of daily
effluent Turbidity); or
b.
demonstrates at least 0.5-log mean removal of micron-sized particulate material
through the Pre-sedimentation, in accordance with 310 CMR 22.20G(22) b.2.
(b)
Two-stage Lime Softening. A Supplier of Water using
Two-stage Lime Softening, subject to the Department's satisfactory review and
written approval, shall receive a 0.5-log Cryptosporidium
treatment credit, if chemical addition and hardness precipitation occur in two
separate and sequential softening stages prior to Filtration, and both
softening stages treat the entire plant flow taken from a Surface Water Source
or a Groundwater under the Direct Influence of Surface Water Source.
(c)
Bank Filtration.
A Supplier of Water using Bank Filtration that serves as pretreatment to a
Filtration plant, subject to the Department's satisfactory review and written
approval of the Bank Filtration data, shall receive
Cryptosporidium
treatment credit, as set forth in 310 CMR 22.20G(2)(c)1. through 8.,
by meeting the following criteria:
1.
Suppliers of Water shall receive either 0.5-log treatment credit for wells with
a groundwater flow path of at least 25 feet or a 1.0-log treatment credit for
wells with a groundwater flow path of at least 50 feet, whichever is less. The
groundwater flow path shall be determined as specified in 310 CMR
22.20G(20)(c)4.;
2. the wells must
be located in granular aquifers. Granular aquifers are comprised of sand, clay,
silt, rock fragments, pebbles or larger particles, and minor cement. A Supplier
of Water must characterize the aquifer at the well site to determine aquifer
properties. A Supplier of Water must extract a core from the aquifer and
demonstrate that in at least 90% of the core length, grains less than 1.0 mm in
diameter constitute at least 10% of the core material;
3. the wells must be horizontal or
vertical;
4. for vertical wells,
the groundwater flow path is the measured distance from the edge of the Surface
Water body under high flow conditions (determined by the 100 year floodplain
elevation boundary or by the floodway, as defined in Federal Emergency
Management Agency flood hazard maps effective as of March 31, 2016) to the well
screen. For horizontal wells, the groundwater flow path is the measured
distance from the bed of the river under normal flow conditions to the closest
horizontal well lateral screen;
5.
each wellhead must be monitored for Turbidity at least once every four hours
while the Bank Filtration is in operation and shall be subject to the following
requirements:
a. if monthly average Turbidity
levels, based on daily maximum values in any of the wells being monitored,
exceed one NTU, the Supplier of Water shall report this result to the
Department and conduct an assessment within 30 days to determine the cause of
the high Turbidity levels in the well; and
b. the Supplier of Water's treatment credit
shall be subject to revocation if the Department determines that microbial
removal has been compromised, until such time as the Supplier of Water
implements corrective actions, as approved by the Department, to remediate the
problem;
6.
Springs and Infiltration Galleries.
a. Springs and infiltration galleries shall
not be eligible for a Bank Filtration treatment credit;
b. Springs and infiltration galleries shall
be eligible for credit pursuant to 310 CMR 22.20G(21)(c);
7.
Bank Filtration Demonstration
of Performance. A Supplier of Water, subject to the Department's
review and written approval, shall receive
Cryptosporidium
treatment credit for Bank Filtration based on submittal of a demonstration of
performance study meeting the following criteria:
a. the study must follow a
Department-approved protocol and must involve the collection of data on the
removal of Cryptosporidium or a surrogate for
Cryptosporidium and related hydrogeologic and water quality
parameters during the full range of operating conditions; and
b. the study must include sampling both from
the production well(s) and from monitoring wells that are screened and located
along the shortest flow path between the Surface Water Source and the
production well(s).
Treatment credit based on a performance study may be greater
than 1.0-log and may be awarded for Bank Filtration that does not meet the
criteria in 310 CMR 22.20G(20)(c)1. through 5.; and
8. Suppliers of Water using Bank
Filtration when they begin source water monitoring under 310 CMR 22.20G(2)(a)
shall collect samples as described in 310 CMR 22.20G(4)(d), but shall not be
eligible for this credit.
(21)
Treatment Performance
Toolbox Components.
(a)
Combined Filter Performance. A Supplier of Water using
Conventional Filtration Treatment or Direct Filtration, subject to the
Department's review and written approval, shall receive a 0.5 log
Cryptosporidium treatment credit during any month the combined
filter effluent (CFE) Turbidity is less than or equal to 0.15 NTU in at least
95% of the measurements. Turbidity must be measured as described in
310 CMR 22.20A(5)(a)
and (c). Such credit shall be in addition to
any other Cryptosporidium treatment credit granted to the
Public Water System pursuant to 310 CMR 22.20G.
(b)
Individual Filter
Performance.
1. A Supplier of
Water using conventional Filtration treatment or Direct Filtration treatment,
subject to the Department's review and written approval, shall receive 0.5-log
Cryptosporidium treatment credit during any month the Public
Water System meets the following criteria:
a.
the filtered water Turbidity for each individual filter must be less than or
equal to 0.15 NTU in at least 95% of the measurements recorded each month;
and
b. no individual filter has a
measured Turbidity greater than 0.3 NTU in two consecutive measurements taken
15 minutes apart.
2. A
Public Water System that has received
Cryptosporidium
treatment credit for individual filter performance that fails to meet the
requirements as specified in 310 CMR 22.20G(21)(b)1.a. or b. during any month
shall not receive a Treatment Technique violation as a result of such failure,
for the month in which the failure occurred, under 310 CMR 22.20G(12)(c), if
the Supplier of Water demonstrates both of the following to the Department's
satisfaction:
a. the failure was due to
unusual and short-term circumstances that could not reasonably be prevented
through optimizing treatment plant design, operation and maintenance;
and
b. the Public Water System has
experienced no more than two such failures in any calendar year.
3. Compliance with these criteria
shall be based on individual filter Turbidity monitoring as described in
310 CMR 22.20A(5)
or
22.20D,
as applicable. Such credit shall be in addition to any other
Cryptosporidium treatment credit granted to the Public Water
System pursuant to 310 CMR 22.20G(21)(a).
(c)
Demonstration of
Performance.
1. A Supplier of
Water, subject to the Department's review and written approval, may be granted
Cryptosporidium treatment credit for drinking water treatment
processes based on a demonstration of performance study that meets the
following criteria:
a. the demonstration of
performance study must follow a Department-approved protocol and must
demonstrate the level of reduction the treatment process will achieve under the
full range of expected operating conditions for the Public Water System;
and
b. the Supplier of Water must
demonstrate and report on any monitoring and treatment performance criteria
designated by the Department, where necessary to verify that the conditions
under which the demonstration of performance credit was approved are maintained
during routine operation.
2. The Cryptosporidium
treatment credit may be greater than or less than the prescribed treatment
credits in 310 CMR 22.20G(12) or (20) through (23) and may be awarded to
treatment processes that do not meet the criteria for the prescribed
credits.
3. A Public Water System
that receives a Cryptosporidium treatment credit pursuant to
310 CMR 22.20G(21)(c) shall be subject to revocation if the Department
determines that the Public Water System no longer satisfies the criteria set
forth in 310 CMR 22.20G(21)(c)1.
4.
A Public Water System that receives a Cryptosporidium
treatment credit for a demonstration of performance study shall not receive a
Cryptosporidium treatment credit for any toolbox option
specified in 310 CMR 22.20G(20) through (23).
(22)
Additional Filtration
Toolbox Components.
(a)
Bag Filters and Cartridge Filters. A Supplier of Water
using Bag Filters or Cartridge Filters that treat the entire plant flow taken
from a Surface Water Source, or Groundwater under the Direct Influence of
Surface Water Source, subject to the Department's review and written approval,
shall receive
Cryptosporidium treatment credit, in accordance
with the following:
1.
Calculation of Credit. A
Cryptosporidium treatment credit of up to 2.0-log for an
individual Bag Filter or Cartridge Filter and up to a 2.5-log for Bag Filters
or Cartridge Filters operated in series shall be granted based on the removal
efficiency demonstrated during challenge testing conducted according to the
criteria in 310 CMR 22.20G(22)(a)2.a. through i. A factor of safety equal to
1-log for individual Bag Filters or Cartridge Filters and 0.5-log for Bag
Filters or Cartridge Filters in series shall be applied to challenge testing
results to determine the Cryptosporidium treatment credit.
Suppliers of Water may use results from challenge testing conducted prior to
January 5, 2006, if the prior testing was consistent with the criteria
specified in 310 CMR 22.20G(22)(a)2.a. through i.
2.
Challenge Testing and
Reporting Procedures.
a.
challenge testing must be performed on full-scale Bag Filters or Cartridge
Filters, and the associated filter housing or pressure vessel, that are
identical in material and construction to the filters and housings the system
will use for removal of Cryptosporidium. Bag Filters or
Cartridge Filters must be challenge tested in the same configuration that the
Public Water System will use, either as individual filters or as a series
configuration of filters;
b.
challenge testing must be conducted using Cryptosporidium or a
surrogate that is removed no more efficiently than
Cryptosporidium. The microorganism or surrogate used during
challenge testing is referred to as the "challenge particulate". The
concentration of the challenge particulate must be determined using a method
capable of discreetly quantifying the specific microorganism or surrogate used
in the test; gross measurements such as Turbidity may not be used;
c. the maximum feed water concentration that
may be used during a challenge test must be based on the detection limit of the
challenge particulate in the filtrate (i.e., filtrate
detection limit) and must be calculated using the following equation: Maximum
Feed Concentration =1 ×104
× (Filtrate
Detection Limit);
d. challenge
testing must be conducted at the maximum design flow rate for the filter as
specified by the manufacturer;
e.
each filter evaluated must be tested for a duration sufficient to reach 100% of
the terminal pressure drop, which establishes the maximum pressure drop under
which the filter may be used while remaining in compliance with the
requirements of 310 CMR 22.20G(22)(a);
f. removal efficiency of a filter must be
determined from the results of the challenge test and expressed in terms of log
removal values using the following equation:
Click to view
image
Where:
LRV = log removal value demonstrated during challenge
testing;
Cf = the feed concentration measured
during the challenge test; and
Cp = the filtrate concentration
measured during the challenge test.
In applying this equation, the same units must be used for the
feed and filtrate concentrations. If the challenge particulate is not detected
in the filtrate, then the term Cp must be set equal to
the detection limit;
g.
each filter tested must be challenged with the challenge particulate during
three periods over the filtration cycle: within two hours of start-up of a new
filter; when the pressure drop is between 45% and 55% of the terminal pressure
drop; and at the end of the cycle after the pressure drop has reached 100% of
the terminal pressure drop. An LRV shall be calculated for each of these
challenge periods for each filter tested. The LRV for the filter
(LRVfilter) shall be assigned the value of the minimum
LRV observed during the three challenge periods for that filter;
h. if fewer than 20 filters are tested, the
overall removal efficiency for the filter product line must be set equal to the
lowest LRVfilter among the filters tested. If 20 or more
filters are tested, the overall removal efficiency for the filter product line
must be set equal to the tenth percentile of the set of
LRVfilter values for the various filters tested. The
percentile is defined by (i/(n+1)) where i is the rank of n individual data
points ordered lowest to highest. If necessary, the tenth percentile may be
calculated using linear interpolation; and
i. the results of challenge testing must be
reported to the Department.
3.
Retesting
Requirement. If a previously tested filter is modified in a manner
that could change the removal efficiency of the filter product line, challenge
testing to demonstrate the removal efficiency of the modified filter must be
conducted and submitted to the Department for a determination of whether such
change will result in an adjustment to the overall
Cryptosporidium treatment credit previously
awarded.
(b)
Membrane Filtration. A Supplier of Water using
Membrane Filtration, subject to the Department's review and written approval,
shall receive
Cryptosporidium treatment credit, in accordance
with the following:
1.
Calculation
of Credit. The level of
Cryptosporidium treatment
credit a Public Water System receives shall be equal to the lower of the values
determined in 310 CMR 22.20G(22)(b)1.a. and b.
a. The removal efficiency demonstrated during
challenge testing conducted under the conditions in 310 CMR
22.20G(22)(b)2.a.
b. The maximum
removal efficiency that can be verified through direct integrity testing used
with Membrane Filtration under the conditions in 310 CMR
22.20G(22)(b)2.b.
2.
Testing and Reporting Procedures.
a.
Challenge
Testing. The membrane used by the Public Water System must undergo
challenge testing to evaluate removal efficiency and the Supplier of Water must
report the results of challenge testing to the Department. Suppliers of Water
may use data from challenge testing conducted prior to January 5, 2006, if the
prior testing was consistent with the criteria specified in 310 CMR
22.20G(22)(b)2.a.i. through viii. Challenge testing must be conducted in
accordance with the following:
i. challenge
testing must be conducted on either a full-scale membrane module, identical in
material and construction to the membrane modules used in the Public Water
System's treatment facility, or a smaller-scale membrane module, identical in
material and similar in construction to the full-scale module.
"Module" as used herein means the smallest component of a
membrane unit in which a specific membrane surface area is housed in a device
with a filtrate outlet structure;
ii. challenge testing must be conducted using
Cryptosporidium oocysts or a surrogate that is removed no more
efficiently than Cryptosporidium oocysts. The organism or
surrogate used during challenge testing is referred to as the "challenge
particulate". The concentration of the challenge particulate, in both the feed
and filtrate water, must be determined using a method capable of discretely
quantifying the specific challenge particulate used in the test; gross
measurements such as Turbidity may not be used;
iii. the maximum feed water concentration
that may be used during a challenge test must be based on the detection limit
of the challenge particulate in the filtrate and must be determined according
to the following equation: Maximum Feed Concentration = 3.16
x106 x (Filtrate Detection Limit);
iv. challenge testing must be conducted under
representative hydraulic conditions at the maximum design flux and maximum
design process recovery specified by the manufacturer for the membrane module.
"Flux" as used in 310 CMR 22.20G means the throughput of a pressure driven
membrane process expressed as flow per unit of membrane area. "Recovery" as
used in 310 CMR 22.20G means the volumetric percent of feed water that is
converted to filtrate over the course of an operating cycle uninterrupted by
events such as chemical cleaning or a solids removal process
(i.e., backwashing);
v. removal efficiency of a membrane module
must be calculated from the challenge test results and expressed as a log
removal value according to the following equation:
Click to view
image
Where:
LRV = log removal value demonstrated during the challenge
test;
Cf = the feed concentration measured
during the challenge test; and
Cp = the filtrate concentration
measured during the challenge test.
Equivalent units must be used for the feed and filtrate
concentrations. If the challenge particulate is not detected in the filtrate,
the term Cp must be set equal to the detection limit for
the purpose of calculating the LRV. An LRV must be calculated for each membrane
module evaluated during the challenge test;
vi. the removal efficiency of a Membrane
Filtration process demonstrated during challenge testing must be expressed as a
log removal value (LRVC-Test). If fewer than 20 modules
are tested, then LRVC-Test must be equal to the lowest
of the representative LRVs among the modules tested. If 20 or more modules are
tested, then LRVC-Test is equal to the tenth percentile
of the representative LRVs among the modules tested. The percentile is defined
by (i/(n+1)) where i is the rank of n individual data points ordered lowest to
highest. If necessary, the tenth percentile may be calculated using linear
interpolation;
vii. the challenge
test must establish a quality control release value (QCRV) for a
non-destructive performance test that demonstrates the Cryptosporidium
removal capability of the Membrane Filtration module. This
performance test must be applied to each production membrane module used in the
Public Water System's treatment facility that was not directly challenge tested
in order to verify Cryptosporidium removal capability.
Production modules that do not meet the established QCRV are not eligible for
the Cryptosporidium treatment credit demonstrated during the
challenge test; and
viii. if a
previously tested membrane is modified in a manner that could change the
removal efficiency of the membrane or the applicability of the non-destructive
performance test and associated QCRV, challenge testing to demonstrate the
removal efficiency of, and determine a new QCRV for, the modified membrane must
be conducted and submitted to the Department for a determination of whether
such change will result in an adjustment to the previously awarded LRV, and an
award of a new LRVC-Test.
b.
Direct Integrity
Testing. The membrane used by the Public Water System must undergo
direct integrity testing in a manner that demonstrates a removal efficiency
equal to or greater than the
Cryptosporidium treatment credit
received pursuant to 310 CMR 22.20G(22)(b)2.a. A "direct integrity test" as
used in 310 CMR 22.00G means a physical test applied to a membrane unit in
order to identify and isolate integrity breaches (
i.e., one or
more leaks that could result in contamination of the filtrate). Direct
integrity testing must be conducted in accordance with the following:
i. the direct integrity test must be
independently applied to each membrane unit in service. A "membrane unit" as
used herein means a group of membrane modules that share common valving that
allows the unit to be isolated from the rest of the Public Water System for the
purpose of integrity testing or other maintenance;
ii. the direct integrity method must have a
resolution of three micrometers or less, where "resolution" as used in 310 CMR
22.20G means the size of the smallest integrity breach that contributes to a
response from the direct integrity test;
iii. the direct integrity test must have
sensitivity sufficient to verify the
Cryptosporidium treatment
credit received pursuant to 310 CMR 22.20G(22)(b)2.a, where "sensitivity" as
used in 310 CMR 22.20G means the maximum log removal value that can be reliably
verified by a direct integrity test. Sensitivity must be determined using the
approach in 310 CMR 22.20G(22)(b)2.b.iii.A. or B., as applicable to the type of
direct integrity test the system uses.
A. For
direct integrity tests that use an applied pressure or vacuum, the direct
integrity test sensitivity must be calculated according to the following
equation:
Click to view
image
Where:
LRVDIT = the sensitivity of the direct
integrity test;
Qp = total design filtrate flow from the
membrane unit;
Qbreach = flow of water from an
integrity breach associated with the smallest integrity test response that can
be reliably measured; and
VCF = volumetric concentration factor. The volumetric
concentration factor is the ratio of the suspended solids concentration on the
high pressure side of the membrane relative to that in the feed water.
B. For direct integrity tests that
use a particulate or molecular marker, the direct integrity test sensitivity
shall be calculated according to the following equation:
Click to view
image
Where:
LRVDIT = the sensitivity of the direct
integrity test;
Cf = the typical feed concentration of
the marker used in the test; and
Cp = the filtrate concentration of the
marker from an integral membrane unit;
iv. Suppliers of Water must establish a
control limit within the sensitivity limits of the direct integrity test that
is indicative of an integral membrane unit capable of meeting the
Cryptosporidium treatment credit awarded by the
Department;
v. if the result of a
direct integrity test exceeds the control limit established under 310 CMR
22.20G(22)(b)2.b.iv., the Supplier of Water must remove the membrane unit from
service. The Supplier of Water must conduct a direct integrity test to verify
any repairs, and may return the membrane unit to service only if the direct
integrity test is within the established control limit; and
vi. Suppliers of Water must conduct direct
integrity testing on each membrane unit at a frequency of not less than once
each day that the membrane unit is in operation, unless otherwise approved by
the Department, based on demonstrated process reliability, the use of multiple
barriers effective for Cryptosporidium, or reliable process
safeguards.
c.
Indirect Integrity Monitoring. Each membrane used by
the Public Water System must undergo continuous indirect integrity monitoring
according to the criteria specified in 310 CMR 22.20G(22)(b)2.c.i. through v.
"Indirect integrity monitoring" as used in 310 CMR 22.20G means monitoring some
aspect of filtrate water quality that is indicative of the removal of
particulate matter. A Supplier of Water that implements continuous direct
integrity testing of membrane units in accordance with the criteria in 310 CMR
22.20G(22)(b)2.b.i. through v. is not subject to the requirements for
continuous indirect integrity monitoring. Monthly reports must be submitted to
the Department summarizing all continuous indirect integrity monitoring results
triggering direct integrity testing and the corrective action that was taken in
each case. Indirect integrity monitoring must be conducted in accordance with
the following:
i. unless the Department
approves an alternative parameter, continuous indirect integrity monitoring
must include continuous filtrate Turbidity monitoring;
ii. continuous monitoring must be conducted
at a frequency of no less than once every 15 minutes;
iii. continuous monitoring must be separately
conducted on each membrane unit;
iv. if indirect integrity monitoring includes
Turbidity and if the filtrate Turbidity readings are above 0.15 NTU for a
period greater than 15 minutes (i.e., two consecutive
15-minute readings above 0.15 NTU), direct integrity testing must immediately
be performed on the associated membrane unit as specified in 310 CMR
22.20G(22)(b)2.b.i. through v.; and
v. if indirect integrity monitoring includes
a Department-approved alternative parameter and if the alternative parameter
exceeds a Department-approved control limit for a period greater than 15
minutes, direct integrity testing must immediately be performed on the
associated membrane units as specified in 310 CMR 22.20G(22)(b)2.b.i. through
v.
(c)
Second stage
Filtration. A Supplier of Water using second stage Filtration that
consists of sand, dual media, GAC, or other fine grain media following granular
media Filtration, subject to the Department's review and written approval based
on an assessment of the design characteristics of the Filtration process, shall
receive 0.5-log
Cryptosporidium treatment credit, in
accordance with the following:
1. the first
stage of Filtration must be preceded by a Coagulation step;
2. both Filtration stages must treat the
entire plant flow taken from a Surface Water Source or Groundwater under the
Direct Influence of Surface Water Source; and
3. a cap, such as GAC, on a single stage of
Filtration shall not be eligible for this Cryptosporidium
treatment credit.
(d)
Slow Sand Filtration (as Secondary Filter). A Supplier
of Water using Slow Sand Filtration (as secondary filter) that follows a
separate stage of Filtration, subject to the Department's review and written
approval based on an assessment of the design characteristics of the Filtration
process, shall receive 2.5-log
Cryptosporidium treatment
credit, in accordance with the following:
1.
both Filtration stages must treat the entire plant flow taken from a Surface
Water Source or Groundwater Under the Direct Influence of Surface Water
Source;
2. no Disinfectant residual
may be present in the influent water to the Slow Sand Filtration process;
and
3. Slow Sand Filtration used as
a primary Filtration process shall not be eligible for this
Cryptosporidium treatment credit.
(23)
Inactivation
Toolbox Components.
(a)
Inactivation by Chlorine Dioxide and Ozone. A Supplier
of Water using chlorine dioxide or ozone, subject to the Department's review
and written approval, shall receive
Cryptosporidium treatment
credit, in accordance with the following:
1.
Calculation of Credit.
a. A Public Water System meeting the chlorine
dioxide CT value in 310 CMR 22.20G(23):
Table 7 for the
applicable water temperature shall receive the corresponding
Cryptosporidium treatment credit.
310 CMR 22.20G: Table 7
CT VALUES (MG ·MIN/L) FOR Cryptosporidium
INACTIVATION BY CHLORINE DIOXIDE1
Log credit
|
Water Temperature, ºC
|
<0.5
|
1
|
2
|
3
|
5
|
7
|
10
|
15
|
20
|
25
|
30
|
0.25
|
159
|
153
|
140
|
128
|
107
|
90
|
69
|
45
|
29
|
19
|
12
|
0.5
|
319
|
305
|
279
|
256
|
214
|
180
|
138
|
89
|
58
|
38
|
24
|
1.0
|
637
|
610
|
558
|
511
|
429
|
360
|
277
|
179
|
116
|
75
|
49
|
1.5
|
956
|
915
|
838
|
767
|
643
|
539
|
415
|
268
|
174
|
113
|
73
|
2.0
|
1275
|
1220
|
1117
|
1023
|
858
|
719
|
553
|
357
|
232
|
150
|
98
|
2.5
|
1594
|
1525
|
1396
|
1278
|
1072
|
899
|
691
|
447
|
289
|
188
|
122
|
3.0
|
1912
|
1830
|
1675
|
1534
|
1286
|
1079
|
830
|
536
|
347
|
226
|
147
|
1 A Supplier of Water may use this
equation to determine log credit between the indicated values: log credit =
(0.001506 x (1.09116)Temp) x CT.
b. A Public Water System meeting the ozone CT
value in 310 CMR 22.20G:
Table 8 for the applicable water
temperature shall receive the corresponding
Cryptosporidium
treatment credit.
310 CMR 22.20G: Table 8
CT VALUES (MG MIN/L) FOR Cryptosporidium
INACTIVATION BY OZONE1
Log credit
|
Water Temperature, ºC
|
<0.5
|
1
|
2
|
3
|
5
|
7
|
10
|
15
|
20
|
25
|
30
|
0.25
|
6.0
|
5.8
|
5.2
|
4.8
|
4.0
|
3.3
|
2.5
|
1.6
|
1.0
|
0.6
|
0.39
|
0.5
|
12
|
12
|
10
|
9.5
|
7.9
|
6.5
|
4.9
|
3.1
|
2.0
|
1.2
|
0.78
|
1.0
|
24
|
23
|
21
|
19
|
16
|
13
|
9.9
|
6.2
|
3.9
|
2.5
|
1.6
|
1.5
|
36
|
35
|
31
|
29
|
24
|
20
|
15
|
9.3
|
5.9
|
3.7
|
2.4
|
2.0
|
48
|
46
|
42
|
38
|
32
|
26
|
20
|
12
|
7.8
|
4.9
|
3.1
|
2.5
|
60
|
58
|
52
|
48
|
40
|
33
|
25
|
16
|
9.8
|
6.2
|
3.9
|
3.0
|
72
|
69
|
63
|
57
|
47
|
39
|
30
|
19
|
12
|
7.4
|
4.7
|
1 A Supplier of Water may use this
equation to determine log credit between the indicated values: log credit =
(0.0397 x (1.09757)Temp) x CT.
c. CT must be calculated at least once each
day, with both C and T being measured during peak hourly flow as specified in
310 CMR 22.20A(5)(a)
through (b).
d. for a Public Water System which includes
several Disinfection segments in sequence, CT must be calculated for each
segment. "Disinfection segment" as used herein means a treatment unit process
with a measurable Disinfectant residual level and a liquid volume.
2.
Site-specific
Study. A Supplier of Water may conduct a site-specific study,
using a protocol pre-approved by Department, demonstrating a higher
inactivation in support of a greater Cryptosporidium treatment
credit than shown in 310 CMR 22.20G: Table 7 or Table
8.
(b)
Inactivation by Ultraviolet Light. A Supplier of Water
using UV light, subject to the Department's review and written approval, shall
receive
Cryptosporidium,
Giardia lamblia, and
Virus treatment credits, in accordance with the following:
1. Calculation of credits.
a. achieve the UV dose values in 310 CMR
22.20G:
Table 9 to receive the corresponding
Cryptosporidium,
Giardia lamblia, and Virus
treatment credits;
310 CMR 22.20G: Table 9
UV DOSE TABLE FOR Cryptosporidium,
Giardia lamblia, and VIRUS INACTIVATION CREDIT
Log credit
|
Cryptospridium\UV dose
(mJ/cm2)
|
Giardia lamblia UV dose
(mJ/cm2)
|
Virus UV dose
(mJ/cm2)
|
0.5
|
1.6
|
1.5
|
39
|
1.0
|
2.5
|
2.1
|
58
|
1.5
|
3.9
|
3.0
|
79
|
2.0
|
5.8
|
5.2
|
100
|
2.5
|
8.5
|
7.7
|
121
|
3.0
|
12
|
11
|
143
|
3.5
|
15
|
15
|
163
|
4.0
|
22
|
22
|
186
|
b. the
treatment credits listed in 310 CMR 22.20G: Table 9 shall
apply to UV light at a wavelength of 254 nm as produced by a low-pressure
mercury vapor lamp. To receive treatment credit for other lamp types,
demonstrate an equivalent germicidal dose through reactor validation testing,
as described in 310 CMR 22.20G(23)(b)4.;
c. the UV dose values in 310 CMR 22.20G:
Table 9 are applicable only to post-filter applications of UV
in filtered Public Water Systems, and to unfiltered Public Water Systems;
and
d. treat at least 95% of the
water delivered to the public during each month by UV reactors operating within
validated conditions for the required UV dose, as described in 310 CMR
22.20G(23)(b)1.a. and 4.
2.
Water Quality
Monitoring. Prior to validation testing, a Supplier of Water shall
satisfy the following requirements:
a. sample
the water quality at a location that is immediately upstream from where the UV
reactor is to be installed.
b.
ensure monitoring:
i. represents storm
events, reservoir turnover, seasonal changes, source blending and any variation
in upstream treatment;
ii. is
conducted up to the period of time specified in 310 CMR 22.20G: Table
10. The Department may approve a shorter period of monitoring if the
Supplier of Water can demonstrate that the water quality is stable and does not
change seasonally; and
iii. meets
the water quality limits, specified in 310 CMR 22.20G:
Table
10:
310 CMR 22.20G: Table 10
UV RAW WATER QUALITY CRITERIA
Parameter
|
Frequency1
|
Limits
|
pH (field measurement)
|
Monthly
|
NA
|
Temp. (field measurement)
|
Bi-weekly for one year
|
NA
|
Dissolved iron (mg/L)
|
Quarterly for one year
|
0.1
|
Dissolved manganese (mg/L)
|
Quarterly for one year
|
0.05
|
Turbidity (NTU)
|
Bi-weekly for one year
|
0.3
|
Color (color units)
|
Monthly
|
15
|
Total Hardness (mg/L as
CaCO3)
|
Quarterly for one year
|
120
|
Hydrogen Sulfide2
(mg/L)
|
Quarterly for one year
|
0.2
|
Alkalinity (mg/L as
CaCO3)
|
Quarterly for one year
|
NA
|
Suspended Solids (mg/L)
|
Quarterly for one year
|
10.0
|
UV Transmittance at 254nm
|
Bi-weekly for one year
|
NA
|
Spectral
Absorbance3
|
Bi-weekly for one year
|
NA
|
Algae Counts
(cells/mL)4
|
Bi-weekly for one year
|
NA5
|
1 The Department may allow the use
of historical data collected at higher frequencies
2 Groundwater only
3 For the use of medium pressure
reactors only. Absorbance to be measured at 200 - 300 nm
4 Unfiltered supplies only
5 At algae concentration > 70,000
cells/mL additional piloting may be required as part of the UV validation
testing
3.
Additional Raw Water
Treatment. If a Public Water System fails to satisfy the
requirements set forth in 310 CMR 22.20G(23)(b)2.b.iii., the Supplier of Water
may propose and, subject to Department approval pursuant to
310
CMR 22.04, implement additional treatment for
raw water in order to achieve the limits specified in 310 CMR 22.20G:
Table 10.
4.
Reactor Validation Testing. A Supplier of Water must
use UV reactors that have undergone validation testing to determine the
operating conditions under which the reactors deliver the UV dose required in
310 CMR 22.20G(23)(b)1.a. for the applicable credit, subject to the following:
a. validation testing must include either
full scale testing of a reactor that conforms uniformly to the UV reactors used
by the Public Water System and inactivation of a test microorganism whose dose
response characteristics have been quantified with a low pressure mercury vapor
lamp, or an alternative approach in accordance with 310 CMR 22.20G(23)(b)4.b.;
or
b. any alternative approach to
UV validation using protocols established in:
i.
Ultraviolet Disinfection
Guidelines for Drinking Water and Water Reuse, 3rd
Edition, August 2012, published by National Water Research
Institute in collaboration with AWWA Research Foundation, pp 1-78; or
ii.
Ultraviolet Microbiological Water
Treatment Systems, NSF/ANSI 55-2014, October 16, 2014, Appendix A and
B, pp.1-36, published by NSF/ANSI; and
c. operating conditions must include flow
rate, UV intensity as measured by a UV sensor, and UV lamp status; which must
account for the following factors: UV absorbance of the water; lamp fouling and
aging; measurement uncertainty of on-line sensors; UV dose distributions
arising from the velocity profiles through the reactor; failure of UV lamps or
other critical system components; and inlet and outlet piping or channel
configurations of the UV reactor.
5.
Reactor Monitoring,
Verification and Calibration.
a.
A Supplier of Water must monitor UV reactors to determine if the reactors are
operating within validated conditions, as identified in 310 CMR
22.20G(23)(b)4.
b. A Supplier of
Water must submit monitoring results to the Department on a monthly basis on a
form approved by the Department for review and evaluation in a format approved
by the Department.
c. A Supplier of
Water must monitor UV intensity as measured by a UV sensor(s), flow rate, lamp
status, UV transmittance, or "UVT", and other appropriate parameters based on
UV reactor operation.
d. A Supplier
of Water must calibrate the UV reactor flow meters annually.
e. A Supplier of Water must verify the
calibration of the UV sensors monthly and recalibrate the sensors annually,
each in accordance with manufacturer's specifications.
f. A Supplier of Water must verify the
calibration of UVT analyzers annually for UV reactors using the "Setpoint
Approach". The Setpoint Approach, also called "Operational Setpoint", uses a
specific value for a critical parameter, such as UV intensity, that is related
to UV dose. Setpoints are established during validation testing. During
operations, the PWS compares the measured parameter to the setpoint to confirm
performance.
g. A Supplier of Water
must verify the calibration of UV transmittance analyzers weekly for UV
reactors using the "Calculated Dose Approach". The Calculated Dose Approach
uses a dose-monitoring equation to estimate the UV dose based on operating
conditions (typically flow rate, UV intensity, and UVT).
h. A Supplier of Water must verify the UVT
reading of the reactor by comparing the UVT obtained from the on-line UVT
transmitter against the UVT of a grab sample. The difference in reading between
the on-line analyzer reading and the grab sample must be less than or equal to
two percent of the UVT.